References
- Barka T., Anderson P. J. Histochemistry. Theory, practice and bibliography. Harper and Row, Publ. Inc., New York, Evanston and London 1963; 240
- Hellström K. E., Sjögren H. O., Warner G. A. Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int. J. Cancer 1971; 7: 1–12
- Hellström K. E., Hellström J. Lymphocyte mediated cytotoxicity and blocking serum activity to tumor antigens. Adv. Immunol. 1973; 18: 209–216
- Kumar S., Taylor G., Steward J. K., Waghe M. A., Pearsson A. Cellular immunity in Wilm's tumor and neuroblastomas. Int. J. Cancer 1972; 10: 26–42
- Larsson S.-E., Lorentzon R., Wedrén H., Boquist L. Osteosarcoma. A multifactorial clinical and histopathological study with special regard to therapy and survival. Acta orthop. scand. 1978a; 49: 571–581
- Larsson S.-E., Lorentzon R., Boquist L. Telangiectatic osteosarcoma. A clinical, roentgenological and morphological study. Acta orthop. scand. 1978b; 49: 589–594
- Lewis M. G., Ikonopisov R. L., Nairn R. C., Phillips T. M., Hamilton-Fairley G., Bodenham D. C., Alexander P. Tumor-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Brit. med. J. 1969; 3: 547–555
- Marcove R. C., Southam C. M., Levin A. A clinical trial of autogenous vaccine in osteogenic sarcoma in patients under the age of twenty-five. Surg. Forum 1971; 22: 434–435
- Marsh B, Flynn L., Enneking W. Immunologic aspects of osteosarcoma and their application to therapy. J. Bone Jt. Surg. 1972; 54-A: 1367–1389
- Miller C. W., DeBlasi R. F., Fisher S. J. Immunological studies in murine osteosarcoma. J. Bone Jt. Surg. 1976; 58-A: 312–317
- Urist M. R., Nakata N., Felser J. M., Nogami H., Hanamura H., Miki T., Finerman G. Am M. An osteosarcoma cell and matrix retained morphogen for normal bone formation. Clin. Orthop. 1977; 124: 251–266
- Urovitz E. P., Cristrom A. A., Langer F., Gorss A. E., Pritzker K. P. H. Immunogenicity of virus-induced rat osteosarcoma. J. Bone Jt. Surg. 1976; 58-A: 308–311